<--- Back to Details
First PageDocument Content
Sulfonamides / Protease inhibitors / Carbamates / Non-nucleoside reverse transcriptase inhibitors / Ritonavir / Delavirdine / Efavirenz / Dofetilide / Itraconazole / Chemistry / Organic chemistry / Pfizer
Date: 2014-09-07 09:10:01
Sulfonamides
Protease inhibitors
Carbamates
Non-nucleoside reverse transcriptase inhibitors
Ritonavir
Delavirdine
Efavirenz
Dofetilide
Itraconazole
Chemistry
Organic chemistry
Pfizer

Kentucky Department for Medicaid Services Drug Management Review Advisory Board (DMRAB) Recommendations for Consideration The following chart provides a summary of the recommendations that were made by the Drug Managemen

Add to Reading List

Source URL: www.chfs.ky.gov

Download Document from Source Website

File Size: 60,84 KB

Share Document on Facebook

Similar Documents

BMS_Gilead_Logo_FINAL.eps

BMS_Gilead_Logo_FINAL.eps

DocID: 1m38a - View Document

New Zealand Consumer Medicine Information  Viramune Tablets and Oral Suspension Nevirapine

New Zealand Consumer Medicine Information Viramune Tablets and Oral Suspension Nevirapine

DocID: 1gvCL - View Document

Viramune Tablets Viramune Oral Suspension Nevirapine Consumer Medicine Information

Viramune Tablets Viramune Oral Suspension Nevirapine Consumer Medicine Information

DocID: 1gtrY - View Document

ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL

ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL

DocID: 1fNy0 - View Document

1 DECEMBER  Correspondence HIV-1 Genotypic DrugResistance Interpretation Algorithms Need to Include HypersusceptibilityAssociated Mutations

1 DECEMBER Correspondence HIV-1 Genotypic DrugResistance Interpretation Algorithms Need to Include HypersusceptibilityAssociated Mutations

DocID: 1fw0V - View Document